Who is still suffering from tuberculosis in Canada?
“Globally, it’s well-controlled in Canada, but we really have to double our efforts in transmission zones, to move from tuberculosis control to eradication”, said Dr. Marcel A. Behr, McGill University Health Centre (MUHC) microbiologist-in-chief and director of the McGill International TB (tuberculose) Centre. The Global Fund to fight AIDS, Tuberculosis and Malaria Replenishment Conference took place in Montréal on September 16 and 17. Stakeholders from different fields reconvened to raise funds against these devastating epidemics, with the aim of ending them by 2030. For more information, visit ICI Radio-Canada.
Rare disorders in children: “Research is necessary”
Until three months old, Naéva was a little girl with normal development. However, things changed very suddenly and at seven months tests showed she suffered from leukodystrophy, a rare and terminal genetic disorder. Naéva died in February 2013.
One in 7,000 children is affected by the disorder and about 50 are followed at the Montreal Children’s Hospital. Unfortunately, research funding for rare diseases like this one is difficult to obtain and there is still a lot of work to be done to find a cure. To find out more, visit TVA Nouvelles.
Young Montrealers targeted in new campaign to raise money for Alzheimer's research
Montreal Alzheimer Research for a Cure (MARC) targets younger donors by reminding them they will have a one in five chance of developing Alzheimer’s, or related disorders, in their senior years if something isn’t done now to combat the illness. It was launched just in time for World Alzheimer’s Day on Sept. 21. Spearheaded by local philanthropist Dorothy Reitman, this joint project of the Jewish General Hospital and the Montreal Neurological Institute is the first online fundraising program dedicated to exclusively supporting Montreal-based research targeting the early detection and treatment of Alzheimer’s and related dementia. It has recruited two internationally-recognized local researchers who are considered trailblazers on the road to a new treatment. For more details, visit the Montreal Gazette.
[view:related_content=block_2]